Habitual

Habitual is a digital-first diabetes prevention & reversal programme that delivers lifelong weight loss and behaviour change.

First Year of Investment 2020
Type of Investment Labs
Investment Lead Dele Akinyemi

Habitual’s mission is to end type 2 diabetes by combining digital therapeutics with a nutritionally-complete food product—an unprecedented combination of two clinically-validated tools that holds the potential to prevent and reverse lifestyle disease across the globe.

Habitual was built in collaboration with behaviour change specialists and psychologists from Harvard Medical School, the University of Cambridge and Stanford University. The three-part program is designed for disease reversal and focuses on total diet replacement, personalised habit-change, and ongoing support to achieve long-term weight maintenance.

Newsletter Sign Up

Sign up for latest news